The Valley Desk

ArticleScience advancesPublished

N-MYC impairs innate immune signaling in high-grade serous ovarian carcinoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Science advances
Published
Subject terms
Cell Line, Tumor; Humans; Cystadenocarcinoma, Serous; Ovarian Neoplasms; Adaptor Proteins, Signal Transducing; Proto-Oncogene Proteins c-myc; Interferon Type I; Membrane Proteins; Signal Transduction; Gene Expression Regulation, Neoplastic; Female; Immunity, Innate
PubMed ID
38748789
PubMed Central ID
PMC11095474
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal